First Quadrant’s West Pharmaceutical WST Stock Holding History

First Quadrant’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-86	Closed	-$24K	–	600
2021 Q1	$24K	Hold	86	–	–	﹤0.01%	525
2020 Q4	$24K	Hold	86	–	–	﹤0.01%	504
2020 Q3	$24K	Hold	86	–	–	﹤0.01%	538
2020 Q2	$20K	Sell	86 -654	-88%	-$128K	﹤0.01%	680
2020 Q1	$113K	Sell	740 -7,623	-91%	-$1.17M	0.02%	447
2019 Q4	$1.26M	Buy	+8,363	New	+$1.22M	0.11%	192
2019 Q3	–	Sell	-15,619	Closed	-$1.96M	–	688
2019 Q2	$1.96M	Buy	+15,619	New	+$1.84M	0.14%	190
2018 Q4	–	Sell	-147,348	Closed	-$18.2M	–	876
2018 Q3	$18.2M	Hold	147,348	–	–	0.4%	89
2018 Q2	$14.6M	Sell	147,348 -147,187	-50%	-$13.5M	0.27%	122
2018 Q1	$26M	Buy	294,535 +14,640	+5%	+$1.37M	0.5%	55
2017 Q4	$27.6M	Hold	279,895	–	–	0.52%	43
2017 Q3	$26.9M	Buy	279,895 +1,221	+0.4%	+$110K	0.52%	41
2017 Q2	$26.3M	Sell	278,674 -6,305	-2%	-$580K	0.53%	46
2017 Q1	$23.3M	Buy	284,979 +65,632	+30%	+$5.49M	0.46%	73
2016 Q4	$18.6M	Buy	219,347 +125,301	+133%	+$9.85M	0.38%	87
2016 Q3	$7.01M	Buy	+94,046	New	+$7.47M	0.15%	200

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

First Quadrant's WST Position: Q2 2021 in Review

First Quadrant sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 86 shares — an estimated $24K sold.

First Quadrant first reported a position in WST in Q3 2016 and held it in 16 quarters. The position peaked at $27.6M in Q4 2017. 639 funds tracked by Wall St. Rank hold WST as of Q2 2021.

First Quadrant reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
First Quadrant sold 86 West Pharmaceutical shares in Q2 2021, an estimated $24K.
First Quadrant first reported a position in West Pharmaceutical in Q3 2016 and held it in 16 quarters.
First Quadrant's West Pharmaceutical position peaked at $27.6M in Q4 2017.
639 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on First Quadrant's 13F filing for Q2 2021, filed 23 Jul 2021.